Calcirut-Forte Tablet

Calcium Aspartate 500 mg + Calcium Orotate 100 mg + Zinc Tablets — Chelated Calcium

Calcirut-Forte Tablet — Calcium Aspartate 500 mg + Calcium Orotate 100 mg + Zinc from Trumac Healthcare PCD Pharma Franchise India

Composition Calcium Aspartate 500 mg + Calcium Orotate 100 mg + Zinc
Dosage Form Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 1450
Therapy G.P. + Orthopaedics + Gynaecology — Chelated Calcium Salt + Zinc Supplement
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Calcirut-Forte Tablet

Calcirut-Forte Tablet provides chelated calcium in two complementary forms: Calcium Aspartate 500 mg and Calcium Orotate 100 mg, supplemented with Zinc. Both calcium salts are amino-acid or organic-acid chelates designed for enhanced absorption and tissue delivery compared to conventional inorganic calcium salts.

Calcium Orotate is particularly noted for its ability to cross cellular membranes more efficiently, delivering calcium intracellularly. Calcium Aspartate provides calcium bound to an amino acid that itself participates in cellular metabolism. Zinc is essential for over 300 enzymes including those involved in bone mineralisation and immune function.

Calcirut-Forte is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a premium chelated-calcium SKU.

Indications

  • Osteoporosis and bone-density maintenance
  • Calcium deficiency requiring enhanced bioavailability
  • Adjunct therapy with antiresorptive drugs
  • Post-menopausal calcium support
  • Calcium supplementation in patients with PPI use or reduced gastric acid

Mechanism of Action

Calcium chelates (aspartate, orotate) provide calcium bound to organic acids or amino acids, increasing membrane permeability and cellular uptake. Calcium Orotate is associated with intracellular calcium delivery. Zinc cofactors alkaline phosphatase activity and osteoblast function, supporting bone mineralisation.

Dosage & Administration

Adults: 1 tablet once or twice daily after meals, or as directed by physician.

Side Effects

Generally well tolerated. Mild GI upset, occasional constipation. Rare hypercalcaemia.

Contraindications & Precautions

Hypersensitivity. Hypercalcaemia. Hyperparathyroidism. Severe renal impairment.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Calcirut-Forte Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Calcirut-Forte Tablet used for?

Calcirut-Forte provides chelated calcium (Calcium Aspartate + Calcium Orotate) with Zinc — used for osteoporosis, post-menopausal bone health and calcium deficiency requiring enhanced absorption.

What is special about chelated calcium?

Chelated forms (calcium bound to organic acids/amino acids) are believed to have enhanced cellular uptake and bioavailability compared to inorganic salts like calcium carbonate, particularly useful in patients with reduced gastric acid.

Is Calcirut-Forte available for PCD pharma franchise?

Yes, on monopoly-based PCD pharma franchise and third-party manufacturing.

How should Calcirut-Forte be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Calcirut-Forte WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.